TrialAlimentary pharmacology & therapeutics2016

Randomised clinical trial: a phase 1, dose-ranging study of the anti-matrix metalloproteinase-9 monoclonal antibody GS-5745 versus placebo for ulcerative colitis.

W J Sandborn et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.